Significance of cytosolic hyaluronan levels in gastric cancer

European Journal of Surgical Oncology

Volumn 30, Issue 3, 2004, Pages 318-324

  Vizoso, F J ^a,b   del Casar, J M ^a   Corte, M D ^b   Garcia I ^c   Corte, M G ^b   Alvarez, A ^c   Garcia Muniz J L ^b,c  

^a HOSPITAL DE JOVE   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

CD44; Gastric cancer; Hyaluronic acid; Prognosis

Indexed keywords

HYALURONIC ACID;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; ENZYME IMMUNOASSAY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER; SURVIVAL RATE; TUMOR CLASSIFICATION;

EID: 1842435206     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.11.007     Document Type: Article

References (33)

1. Prehm P. Hyaluronate is synthesized at plasma membranes. Biochem J 1984;220:597-600.
2. Fraser J, Laurent T, Laurent U. Hyaluronan: Its nature, distribution, functions and turnover. J Intern Med 1997;242: 27-33.
3. Toole BP. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 1990;2:839-844.
4. Arai H, Kang KY, Sato H et al. Significance of the quantification and demonstration of hyaluronic acid in tissue specimens for the diagnosis of pleural mesothelioma. Am Rev Respir Dis 1979; 120:529-532.
5. Hopwood JJ, Dorfman A. Glycosaminoglycan synthesis by Wilms' tumor. Pediatr Res 1978; 12:52-56.
6. Auvinen PK, Parkkinen JJ, Johansson RT et al. Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer 1997;74:477-481.
7. Wang C, Tammi M, Guo H, Tammi R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 1996; 148:1861-1869.
8. Sowa M, Kato Y, Nishimura M, Yoshino H, Kubo T, Umeyama K. Clinico-histochemical studies on type 4 carcinoma of the stomach-with special reference to mucopolysaccharides and sialic acid in tumor tissue. Jpn J Surg 1989; 19:153-162.
9. Setala LP, Tammi MI, Tammi RH et al. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer 1999;79: 1133-1138.
10. Goebeler M, Kaufmann D, Brocker EB, Klein CE. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci 1996; 109:1957-1964.
11. Catterall J, Gardner M. Hyaluronic acid, cell adhesion and metastasis. Cancer J 1995;8:320-324.
12. Rooney P, Kumar S, Ponting J, Wang M. The role of hyaluronan in tumour neovascularization (review). Int J Cancer 1995;60:632-636.
13. Zhang L, Underhill CB, Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 1995;55:428-433.
14. Rudzki Z, Jothy S. CD44 and the adhesion of neoplastic cells. Mol Pathol 1997;50:57-71.
15. McBride WH, Bard JB. Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J Exp Med 1979; 149:507-515.
16. Kohno N, Ohnuma T, Truog P. Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality. J Cancer Res Clin Oncol 1994; 120:293-297.
17. Anttila MA, Tammi RH, Tammi MI, Syrjanen KJ, Saarikoski SV, Kosma VM. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 2000;60:150-155.
18. Auvinen P, Tammi R, Parkkinen J et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000; 156:529-536.
19. Wernicke M, Pineiro L, Caramutti D et al. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod Pathol 2003; 16:99-107.
20. Llaneza A, Vizoso F, Rodriguez JC et al. Hyaluronic acid as prognostic marker in resectable colorectal cancer. Br J Surg 2000;87:1690-1696.
21. Garcia I, Vizoso F, Suarez C et al. Relationship of tumoral hyaluronic acid and cathepsin D contents with histological type of gastric carcinoma. Int J Biol Markers 2000;15: 215-218.
22. Hermaneck P, Sobin L. UICC TNM classification of malignant tumors 6th ed. Berlin: Springer, 2002.
23. Cox D. Regression models and life tables. J R Stat Soc B 1972; 34:187-220.
24. Knudson W, Biswas C, Toole BP. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci U S A 1984;81:6767-6771.
25. Brown CT, Applebaum E, Banwatt R, Trinkaus-Randall V. Synthesis of stromal glycosaminoglycans in response to injury. J Cell Biochem 1995;59:57-68.
26. Knudson W, Biswas C, Li XQ, Nemec RE, Toole BP. The role and regulation of tumour-associated hyaluronan. Ciba Found Symp 1989; 143:150-159.
27. Culty M, Nguyen H, Underhill C. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992; 116:1055-1062.
28. Culty M, Shizari M, Thompson EW, Underhill CB. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential. J Cell Physiol 1994; 160:275-286.
29. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 1993;122:257-264.
30. Yamamichi K, Uehara Y, Kitamura N, Nakane Y, Hjoki K. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer. Int J Cancer 1998;79:256-262.
31. Li H, Guo L, Li JW, Liu N, Qi R, Liu J. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: Relevance with tumor progression. Int J Oncol 2000;17: 927-932.
32. Yamaguchi A, Goi T, Yu J et al. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis. J Surg Oncol 2002; 79:230-235.
33. Lokeshwar VB, Lokeshwar BL, Pham HT, Block NL. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res 1996; 56:651-657.